Literature DB >> 18313549

Surgical therapy for colorectal adenocarcinoma.

Neal Wilkinson1, Carol E H Scott-Conner.   

Abstract

Colorectal cancer (CRC) remains the second leading cause of cancer mortality among men, and the third leading cause among women. Worldwide, CRC is the fourth most common cancer with approximately 1 million new cases annually. Unfortunately, advanced disease at diagnosis is still all too common. Locally advanced rectal cancer, node-positive colon cancer, and metastatic disease still compose a significant proportion of colon and rectal cancer. Surgery is the mainstay of treatment, providing definitive management and potential cure in early cases, and effective palliation in advanced cases. Chemotherapy and, sometimes, radiotherapy are essential components of effective treatment. This article briefly reviews the general principles of surgical management and describes recent developments.

Entities:  

Mesh:

Year:  2008        PMID: 18313549     DOI: 10.1016/j.gtc.2007.12.012

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  14 in total

1.  Expression of cell cycle regulators p21 and p27 as predictors of disease outcome in colorectal carcinoma.

Authors:  Jaudah Al-Maghrabi; Mahmoud Al-Ahwal; Abdelbaset Buhmeida; Kari Syrjänen; Abdulrahman Sibyani; Eman Emam; Ayman Ghanim; Mohmmad Al-Qahtani
Journal:  J Gastrointest Cancer       Date:  2012-06

Review 2.  Cancer stem cells: a novel paradigm for cancer prevention and treatment.

Authors:  Dharmalingam Subramaniam; Satish Ramalingam; Courtney W Houchen; Shrikant Anant
Journal:  Mini Rev Med Chem       Date:  2010-05       Impact factor: 3.862

3.  Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects.

Authors:  Zhiyun He; Dharmalingam Subramaniam; Satish Ramalingam; Animesh Dhar; Russell G Postier; Shahid Umar; Youcheng Zhang; Shrikant Anant
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

4.  Up-regulation of neutrophil gelatinase-associated lipocalin in colorectal cancer predicts poor patient survival.

Authors:  Herbert Thomas Maier; Felix Aigner; Birgit Trenkwalder; Matthias Zitt; Natalie Vallant; Alexander Perathoner; Christian Margreiter; Patrizia Moser; Johann Pratschke; Albert Amberger
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

5.  Laparoscopic Colorectal Cancer Resection in High-Volume Surgical Centers: Long-Term Outcomes from the LAPCOLON Group Trial.

Authors:  Cristiano G S Huscher; Frederic Bretagnol; Francesco Corcione
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

6.  Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma.

Authors:  Jaudah Al-Maghrabi; Abdelbaset Buhmeida; Eman Emam; Kari Syrjänen; Abdulrahman Sibiany; Mohmmad Al-Qahtani; Mahmoud Al-Ahwal
Journal:  World J Gastroenterol       Date:  2012-04-21       Impact factor: 5.742

7.  Metastatic adenocarcinoma of the colon: early manifestation in gingival tissue.

Authors:  Andresa Borges Soares; Luiz Alexandre Thomaz; Mauricio Texeira Duarte; Paulo de Camargo de Moraes; Vera Cavalcanti de Araújo
Journal:  Head Neck Pathol       Date:  2010-11-16

8.  Expression of granulocyte colony-stimulating factor receptor in rectal cancer.

Authors:  Xiao-Dong Yang; Ping Huang; Feng Wang; Ze-Kuan Xu
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

Review 9.  Laparoscopic versus open surgery for the treatment of colorectal cancer: a literature review and recommendations from the Comité de l'évolution des pratiques en oncologie.

Authors:  Mélanie Morneau; Jim Boulanger; Patrick Charlebois; Jean-François Latulippe; Rasmy Lougnarath; Claude Thibault; Normand Gervais
Journal:  Can J Surg       Date:  2013-10       Impact factor: 2.089

10.  Circulating cytokeratin 18 fragment m65-a potential marker of malignancy in colorectal cancer patients.

Authors:  Christoph Ausch; Veronika Buxhofer-Ausch; Ulrike Olszewski; Rudolf Schiessel; Emil Ogris; Wolfgang Hinterberger; Gerhard Hamilton
Journal:  J Gastrointest Surg       Date:  2009-09-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.